Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

This study is testing whether an AI tool applied to a vaginal ultrasound can accurately identify endometrial cancer or a pre-cancerous condition (atypical hyperplasia) in women who have experienced post-menopausal bleeding, without needing invasive testing. **You may be eligible if...** - You are 55 years or older - You have experienced at least one episode of bleeding after menopause - You have had an endometrial biopsy performed at Mayo Clinic or an affiliated institution - You are willing to undergo a transvaginal ultrasound **You may NOT be eligible if...** - Your diagnostic tests were performed more than 90 days apart - You are unable or unwilling to undergo a transvaginal ultrasound Talk to your doctor to see if this trial is right for you.